Results 111 to 120 of about 2,785 (167)

Pre-Operative Bone Health in Elective Spine Surgery, From Risk Assessment to Optimization Strategies: A Narrative Review. [PDF]

Global Spine J
Ng MK, Hitchner M, Dalton J, Lee Y, Green WA, Baek G, Mathew J, Eichbaum YK, Hilibrand AS, Vaccaro AR, Schroeder GD, Kepler CK.   +11 more
europepmc   +1 more source

The use of romosozumab versus denosumab in patients with osteoporosis. [PDF]

Rev Assoc Med Bras (1992)
Floriano I, Silvinato A, Bernardo WM.
europepmc   +1 more source

Romosozumab-Induced Epidural Calcification in a Hemodialysis Patient. [PDF]

Cureus
Yoshikawa S.
europepmc   +1 more source

Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort. [PDF]

Bone Rep
Corredor DC, Pascual LÁC.
europepmc   +1 more source

ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study. [PDF]

Osteoporos Int
Adami G, Bartezaghi M, Montanari F, Piccinelli A, Pollastri F, Mastropaolo F, Giorgio F, Benini C, Fassio A, Rossini M, Gatti D, Fornari R, Viapiana O.   +12 more
europepmc   +1 more source

Bone Optimization for Perioperative Spine Patients: A Multidisciplinary Approach at a Single Academic Center. [PDF]

J Clin Med
Suarez-Nieto MV, Malacon K, Fox A, Lopez Isidro MC, Wadhwa H, Hu SS, Zygourakis CC.   +6 more
europepmc   +1 more source

Timeliness of Antiresorptive Consolidation After Anabolic Therapy for Primary Fracture Prevention: A U.S. Cohort Study. [PDF]

J Clin Endocrinol Metab
Badour S, McCoy RG, Takagi M, Everhart AO, Parimi J, Herrin J, Karaca-Mandic P, Wermers RA, Rosen CJ, Brito JP.   +9 more
europepmc   +1 more source

[Diagnosis and management of diabetes and co-existing osteoporosis (Update 2026)]. [PDF]

Wien Klin Wochenschr
Muschitz C, Kautzky-Willer A, Rauner M, Winhöfer-Stöckl Y, Haschka J.   +4 more
europepmc   +1 more source

Assessing cortical bone changes with Romosozumab after one year: Insights from an exploratory HR-pQCT study. [PDF]

Bone Rep
Zanchetta MB, Gonzalez-Pernas M, Jerkovich F, Pingel J, Schwartz N, Erdociain L, Zanchetta JR.   +6 more
europepmc   +1 more source

Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab. [PDF]

Osteoporos Int
Liu Y, Arora T, Zhang J, Sen B, Becker D, Sun R, Yun H, Saag KG, Curtis JR.   +8 more
europepmc   +1 more source